ClinicalTrials.gg
Drug

Macitentan clinical trials

Also written ACT-064992, Opsumit and JNJ-67896062.

studies test it
56
open now
3
in phase 3
23
first study started
2008

How each study uses macitentan is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the macitentan studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
18 Oct 2013 · OPSUMIT · NDA 204410 (FDA, Drugs@FDA)
European Union
20 Dec 2013 · Opsumit · EMEA/H/C/002697 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Macitentan
33
Macitentan 10 mg
10
Macitentan 10mg
4
Macitentan 10 mg tablet, once daily.
3
Macitentan (Opsumit®)
2

Brand

Opsumit
13

Development codes

ACT-064992
23
JNJ-67896062
7

Studies by the year they started

56 studies that test it; most in 2015 (6)

Studies that test macitentan, by start year
YearStudies
20082
20091
20114
20121
20134
20144
20156
20162
20175
20185
20192
20205
20213
20226
20244
20252

By phase

A phase 1/2 study counts in both.

Early Phase 1
2
Phase 1
16
Phase 2
12
Phase 3
23
Phase 4
5

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 46 · Other 10

Actelion (41) · Janssen Pharmaceutical K.K. (2) · Janssen Research & Development, LLC (2) · University of California, Los Angeles (2) · China-Japan Friendship Hospital (2) · Assistance Publique - Hôpitaux de Paris (1) · University of Giessen (1) · Humanis Saglık Anonim Sirketi (1)

Often tested with

Tested in the same studies.

Tadalafil (7) · Riociguat (3) · Rosuvastatin (2) · Sildenafil (1) · Selexipag (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 2, 1 in phase 3

Studies that test macitentan, phase 3 first.

Studies

Open first, then newest update. How each study uses macitentan is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 56

See all 56 studies that test macitentan →

Given beside what is tested · 3 — macitentan is usual care or a partner of the new treatment
As the comparator · 1 — what is tested is compared with macitentan

Codes

What other systems call macitentan · ClinicalTrials.gg INT005368

  • MeSH (NLM) C533860macitentanConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) Z9K9Y9WMVLMACITENTANConfirmed FDA, NLM, Wikidata
  • RxNorm 1442132Confirmed FDA, Wikidata
  • Wikidata Q6724151macitentanConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C87728MacitentanOne source FDA
  • DrugBank DB08932One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.